cbdMD, Inc.
YCBD · AMEX
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $5 | $16 | $17 | $108 |
| - Cash | $0 | $2 | $2 | $7 |
| + Debt | $778 | $1 | $4 | $5 |
| Enterprise Value | $783 | $15 | $19 | $106 |
| Revenue | $0 | $19 | $24 | $35 |
| % Growth | -100% | -19.3% | -31.8% | – |
| Gross Profit | $0 | $12 | $15 | $22 |
| % Margin | – | 61.6% | 62% | 63.1% |
| EBITDA | $0 | -$1 | -$20 | -$15 |
| % Margin | – | -7.7% | -82.8% | -43.7% |
| Net Income | -$4,375 | -$4 | -$23 | -$74 |
| % Margin | – | -19% | -95% | -209.3% |
| EPS Diluted | -1.09 | -1.79 | -13.32 | -55.8 |
| % Growth | 39.1% | 86.6% | 76.1% | – |
| Operating Cash Flow | $0 | -$0 | -$4 | -$15 |
| Capital Expenditures | -$184 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$184 | -$1 | -$5 | -$16 |